Gijs R. van den Brink

Author

Amsterdam UMC Location University of Amsterdam ORCID

Also Known As

Anna Brink, Broxmeyer, Hal E., F G van der Goot, F Gisou van der Goot, F. G. Van Der Goot, F. G. van der Goot, F. Gisou Goot, F. Gisou VAN DER GOOT, F. Gisou Van Der Goot, F. Gisou Van der Goot

548

Publications

45.1K

Citations

102

H-Index

128

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam Leiden University Medical Center University of Amsterdam University Medical Center Utrecht Amsterdam University Medical Centers

About

Gijs R. van den Brink is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	50	7.9K
2	Allergy	5	5	778
3	Natural Sciences	3	3	356
4	Health Sciences	2	2	97
5	Public Health	2	2	92

Gijs R. van den Brink

115

Publications

19K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, Autophagy	2016	5.9K
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties Sarah Schwitalla, Alexander A. Fingerle, Patrizia Cammareri, Cell Developmental BiologyMedicineAdult Stem CellIntestinal Tumorigenesis InitiatedColorectal Cancer	2012	1K
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis Noortje Rossen, Susana Fuentes, Mirjam J. van der Spek, Gastroenterology Intestinal TransplantationGastroenterologyFecal TransplantationRandomized Controlled TrialClinical Gastroenterology	2015	911
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease Jan M. H. van den Brande, Henri Braat, Gijs R. van den Brink, Gastroenterology InflammationAnti-inflammatoryAutoimmune DiseaseCrohn ’Immunology	2003	723
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study Marjolijn Duijvestein, Anne Christine W. Vos, Helene Roelofs, Gut	2010	620
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg, Gastroenterology InflammationChronic Inflammatory DiseasesFunctional Gastrointestinal DisorderMucosal ImmunologyImmunology	2015	410
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation Gijs R. van den Brink, Sylvia A. Bleuming, James C.H. Hardwick, Nature Genetics InflammationDevelopmental BiologySignaling PathwayIndian HedgehogColorectal Cancer	2004	375
Leptin Is a Growth Factor for Colonic Epithelial Cells James C.H. Hardwick, Gijs R. van den Brink, G. J. A. Offerhaus, Gastroenterology InflammationGastrointestinal Peptide HormoneGrowth FactorCytoskeletonGut Barrier	2001	367
Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis Marjolijn Duijvestein, Manon E. Wildenberg, Mick M. Welling, Stem Cells Chronic Inflammatory DiseasesInterferon-γ EnhancesImmunologyImmune RegulationTherapeutic Activity	2011	331
Treatment of bile duct lesions after laparoscopic cholecystectomy. Jacques Bergman, Gijs R. van den Brink, E RAUWS, Gut	1996	318

Page 1